Former FDA, CMS chief Mark McClellan appointed to Cigna’s board
Mark McClellan, MD, a former CMS administrator and a former Commissioner of the FDA, was appointed to Cigna’s board of directors, where he will begin his term Dec. 1.
Earlier this year, Cigna announced its acquisition of Express Scripts for $67 billion. If the deal closes before McClellan’s start date, he will join the board of directors of the combined company at closing.
“Mark’s combination of healthcare industry and economic expertise will strongly support Cigna’s efforts to drive healthcare affordability and quality, as we continue to innovate and deliver differentiated value for our customers, clients and communities—in alignment with healthcare providers,” said Cigna President and CEO David M. Cordani in a prepared statement.
McClellan, a physician and economist, is currently the director of the Robert J. Margolis MD Center for Health Policy at Duke University.
As a senior news writer for TriMed, Subrata covers cardiology, clinical innovation and healthcare business. She has a master’s degree in communication management and 12 years of experience in journalism and public relations.